Perrigo Company plc Business Acquisition, Transaction Costs
Perrigo Company plc (PRGO) had Business Acquisition, Transaction Costs of $3.20 million as of 2014-03-29, per its 10-K filed 2015-08-13.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Description
us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts · last filed 2016-02-25
- 2014-03-29: Business Acquisition, Transaction Costs $3.20M.
- 2013-12-28: Business Acquisition, Transaction Costs $103.20M.
- 2013-09-28: Business Acquisition, Transaction Costs $12.00M.
| Period end | Business Acquisition, Transaction Costs |
|---|---|
| 2014-03-29 | $3.20M 10-K · filed 2015-08-13 |
| 2013-12-28 | $103.20M 10-KT · filed 2016-02-25 |
| 2013-09-28 | $12.00M 10-KT · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |